Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $34.2550 (1.24%) ($34.2550 - $34.2550) on Fri. Apr. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.76% (three month average) | RSI | 29 | Latest Price | $34.2550(1.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.8% a day on average for past five trading days. | Weekly Trend | HALO declines -4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(41%) IWO(39%) XBI(37%) IWM(36%) IBB(35%) | Factors Impacting HALO price | HALO will decline at least -1.38% in a week (0% probabilities). VXX(-14%) UUP(-14%) VIXM(-10%) TBT(-7%) IGOV(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.38% (StdDev 2.76%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $36.43 | 5 Day Moving Average | $35(-2.13%) | 10 Day Moving Average | $35.64(-3.89%) | 20 Day Moving Average | $36.43(-5.97%) | To recent high | -35.7% | To recent low | 4.3% | Market Cap | $4.682b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |